A/s Genmab, 10% Owner at Merus N.V. (MRUS), bought 271,547 shares at $97.00 ($26.3M) on 2025-12-17, disclosed to the SEC on 2025-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.00 | 120,752 | $11.7M | 44.5% |
| 2 | $97.00 | 150,795 | $14.6M | 55.5% |
| Total | $97.00 avg | 271,547 | $26.3M | 100% |
| Filing → |
| MRUS | BUY | 2025-12-22 | $27.0M | — | Filing → |